Elgemtumab Uses, Dosage, Side Effects and more
Elgemtumab is under investigation in clinical trial NCT02167854 (Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer).
| Trade Name | Elgemtumab |
| Generic | Elgemtumab |
| Elgemtumab Other Names | Elgemtumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
